• biotechne
  • R&D Systems™
  • Bio-Techne Spatial™
  • Bio-Techne Diagnostics™
  • 800 343 7475 ir@bio-techne.com
    Investors

    800 343 7475ir@bio-techne.com bio-techne.com

    • Overview
    • News / Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Information
      • Overview
      • Profile
      • Presentations
      • Management Team
      • Contacts
      • FAQ
    • Financial Information
      • Overview
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
      • Annual Reports
    • Stock Data
      • Overview
      • Quote
      • Charts
      • Historical Data
    • SEC Filings
      • Overview
      • All SEC Filings
      • 10-K Filings
      • Quarterly Reports
      • Section 16 Filings
    • Corporate Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
    Navigation

      News / Events

    • Overview
    • News / Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Profile
      • Presentations
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
      • Annual Reports
    • Stock Data
      • Overview
      • Quote
      • Charts
      • Historical Data
    • SEC Filings
      • Overview
      • All SEC Filings
      • 10-K Filings
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents

    Press Releases

    • News / Events

    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    Oct 31, 2023

    BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS

    Oct 31, 2023

    BIO-TECHNE DECLARES DIVIDEND

    Oct 25, 2023

    LEADING RESEARCH INSTITUTES TO PRESENT NEW DATA USING LUNAPHORE'S COMET™ TECHNOLOGY AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 38th ANNUAL MEETING

    Oct 19, 2023

    BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER

    Oct 16, 2023

    BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY

    Oct 10, 2023

    BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS

    Sep 28, 2023

    DR. JORDAN LASER AWARDED AMP MERITORIOUS SERVICE AWARD

    Sep 27, 2023

    SCIENTISTS AT CE PHARM CONFERENCE DESCRIBE HOW Maurice™ AND MauriceFlex™ SYSTEMS TRANSFORM THEIR PROTEIN ANALYSIS

    Sep 26, 2023

    BIO-TECHNE INTEGRATES ITS MAURICE SYSTEM WITH THE THERMO SCIENTIFIC CHROMELEON CHROMATOGRAPHY DATA SYSTEM

    Sep 25, 2023

    BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT

    RSS
    • 1...
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • ...53
    • Email Alerts
    • Contacts
    • RSS News Feed
    Bio-Techne

    614 McKinley Place NE
    Minneapolis, MN 55413
    USA

    TEL 612 379 2956
    Toll-free 800 343 7475
    FAX 612 656 4400

    Who We Are

    • About Bio-Techne
    • Bio-Techne Brands
    • Careers
    • Corporate & Social Responsibility
    • Terms and Conditions

    Investor Relations

    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance

    Stay Connected

    • LinkedIn Twitter YouTube
    • Contact Us

    Utility Footer Menu

    • Privacy Policy
    • Cookie Policy
    • Site Map

    © Copyright 2026 Bio-Techne. All Rights Reserved. All trademarks and registered trademarks are the property of Bio-Techne and its brands unless otherwise specified.